Diabetes and Traditional Medicine: New Research
By D.P. Agrawal
Diabetes is defined as a state in which the homeostasis of carbohydrate and
lipid metabolism is improperly regulated by insulin. It appears that rich food
and sedentary lifestyles have created a worldwide epidemic of this disease.
There are an estimated 143 million people worldwide suffering from diabetes;
a figure which is almost five times as much as the estimates ten years ago.
If the current trend continues, this number will probably double by the year
2030.
Tiwari and Rao have reviewed the state of research in this field in a recent
issue of Current Science. The phytochemicals identified from traditional
medicinal plants are presenting an exciting opportunity for the development
of new types of therapeutics. This has accelerated the global effort to harness
and harvest those medicinal plants that bear a substantial amount of potential
phytochemicals showing multiple beneficial effects in combating diabetes and
diabetes-related complications.
Tea polyphenolics, apart from their much-cited anti-oxidant activities, also
have been reported to inhibit a-amylase and sucrase. Furthermore, these polyphenolics
also inhibit glucose transport across the intestine by inhibiting sodium glucose
co-transporter (S-GLUT-1). Crude saponin fractions from Gymnema sylvestre
(Gurmar in Hindi) and other saponins from several plant extracts have
been shown to possess potent S-GLUT-1-mediated inhibition of glucose and antihyperglycemic
activity.
The α-glucosidase inhibitors are currently the most commonly used oral
agents for ameliorating PPHG (post-prandial hyperglycemia). This is due to
the lack of hypoglycemic threat and, more importantly, because of the prospect
of blood glucose control without hyperinsulinemia and body weight gain. However,
a crude extract of Pterocarpus marsupium [an Ayurvedic medicinal plant
(vijayasar in Hindi) advocated for diabetes mellitus] in the form of
water decoction has been reported to have a protective and a restorative effect
in alloxan-induced diabetic rats. Epi-catechin from P. marsupium was
shown to possess preventive as well as restorative properties of ß-cells against
alloxan-induced damage. Some more flavonoids from P. marsupium, as liquiritigenin
and pterosupin, have been reported to have hypolipidemic properties of these
phytochemicals in experimental animals.
Gymnema sylvestre, an Indian medicinal plant, has long been known to
possess antidiabetic activities. It is popularly known in Hindi as 'gurmar,'
meaning sugar destroyer. This name is attributed to the fact that one of the
plant’s key properties is its capability to suppress an individual’s ability
to taste anything sweet. Extracts of this plant have been reported to possess
a variety of actions related to the antidiabetic properties such as reducing
insulin requirements by possibly enhancing endogenous insulin availability,
improving vitiated blood glucose homeostasis, better controlling of hyperlipidemia
associated with diabetes, and reducing amylase activity. The dried powder of
G. sylvestre was found not only to regulate the blood sugar homeostasis
in alloxan-induced diabetic rats, but also to increase the activity of enzymes
responsible for the utilization of glucose by insulin-dependent pathways. Baskaran
et al studied the effect of extracts of G. sylvestre leaves in
controlling hyperglycemia in Type 2 diabetic patients. The authors observed
that the extract produced a significant reduction in blood glucose, glycosylated
haemoglobin, and glycosylated plasma proteins, with a decrease in conventional
drug dosages. Some patients were able to discontinue conventional drugs and
even maintain their blood glucose homeostasis with extracts alone. In insulin-dependent
patients, prolonged administration of a water-soluble extract of leaves of G.
sylvestre produced a reduction in insulin requirement, improved blood
glucose homeostasis, better controlled hyperlipidemia, and reduced serum amylase
activity.
Hypoglycemic activity of Zizyphus jujuba (Jamun in Hindi) was first
reported on normoglycemic rats. Chemical constituents in Z. jujuba may
have the ability to release insulin from pancreatic ß-cells and also have the
potential to protect it from alloxan-induced damage in experimental animals.
Trigonella foenum-graceum L., or fenugreek seeds (methi in Hindi),
have been reported to possess hypoglycemic and hypolipidemic properties in animal
experiments, as well as in human and clinical cases. The holy basil (tulasi
in Hindi), Ocimum sanctum, and O. album have been observed to
decrease the fasting and postprandial blood and urinary glucose levels in Type
2 diabetic patients. The dried powder of these leaves also mildly reduced cholesterol
level.
Tiwari and Rao emphasize that traditional medicinal preparations should not
be considered just as a collection of therapeutic recipes. They are formulated
and prepared while keeping in mind the conditions of sickness and the healing
properties of individual ingredients. It is important therefore, that herbal
medicines and preparations should be taken with the consideration of their holistic
therapeutic approach. The multiple activities of plant-based medicinal preparations
meant for diabetes offer enormous scope for combating the threat of the diabetic
epidemic.
Unfortunately, despite the apparent supremacy in terms of multiple therapeutic
approaches of herbal medicines, well-organized, rigorous clinical trial evidence
is not adequately available in order to advocate their scientific merit and
supremacy over existing drugs. Though the markets for herbal medicines are
booming and evidence for their effectiveness is growing, it is also being simultaneously
counterbalanced by inadequate regulation. Therefore, the product standardization,
efficacy, safety, and therapeutic risk/benefit associated with the use of herbal
medicines need proper evaluation.
Source:
Ashok K. Tiwari and J. Madhusudana Rao. 2002. Diabetes mellitus and multiple
therapeutic approaches of phytochemicals: present status and future prospects.
Current Science 83(1):30-38.
|